Dr Andrew Reason


Dr Andrew Reason is the founder, Managing Director and CEO of BioPharmaSpec, a US and UK-based niche Contract Research Organisation (CRO) offering structural and physicochemical characterisation of biopharmaceuticals. He has 25 years of experience in analysis of both novel and biosimilar biopharmaceuticals and has been involved in the commercialisation of a number of analytical methods for characterising proteins. In addition to his scientific and managerial duties, Andrew has contributed to many industry publications and is a regular presenter at conferences.

Back Now